| Primary |
| Heart Disease Congenital |
23.8% |
| Peripheral Arterial Occlusive Disease |
14.0% |
| Arteriosclerosis Obliterans |
9.4% |
| Erectile Dysfunction |
9.1% |
| Peripheral Ischaemia |
8.5% |
| Product Used For Unknown Indication |
6.5% |
| Arterial Occlusive Disease |
5.9% |
| Patent Ductus Arteriosus |
2.3% |
| Anticoagulant Therapy |
2.0% |
| Drug Use For Unknown Indication |
2.0% |
| Hypertension |
2.0% |
| Pain |
2.0% |
| Premedication |
2.0% |
| Thrombosis Prophylaxis |
2.0% |
| Type 2 Diabetes Mellitus |
2.0% |
| Lumbar Spinal Stenosis |
1.6% |
| Diabetes Mellitus |
1.3% |
| Procedural Hypotension |
1.3% |
| Skin Ulcer |
1.3% |
| Systemic Sclerosis |
1.3% |
|
| Infantile Apnoeic Attack |
13.6% |
| Priapism |
8.3% |
| Pulmonary Oedema |
8.3% |
| Cerebral Infarction |
6.8% |
| Bradycardia |
6.1% |
| Myocardial Infarction |
5.3% |
| Oxygen Saturation Decreased |
5.3% |
| Pyrexia |
5.3% |
| Vomiting |
5.3% |
| Abdominal Distension |
3.8% |
| Sepsis |
3.8% |
| Ventricular Fibrillation |
3.8% |
| Apnoeic Attack |
3.0% |
| Drug Ineffective |
3.0% |
| Dyspnoea |
3.0% |
| Enterocolitis |
3.0% |
| Haemorrhage |
3.0% |
| Hypotension |
3.0% |
| Pneumonia |
3.0% |
| Post Procedural Complication |
3.0% |
|
| Secondary |
| Product Used For Unknown Indication |
22.2% |
| Erectile Dysfunction |
10.6% |
| Renal Transplant |
8.1% |
| Analgesic Therapy |
7.1% |
| Thrombosis Prophylaxis |
6.6% |
| Therapeutic Embolisation |
6.1% |
| Chillblains |
4.0% |
| Livedo Reticularis |
4.0% |
| Neuralgia |
4.0% |
| Drug Use For Unknown Indication |
3.5% |
| Arthralgia |
3.0% |
| Hyperlipidaemia |
3.0% |
| Liver Transplant |
2.5% |
| Peripheral Arterial Occlusive Disease |
2.5% |
| Unevaluable Event |
2.5% |
| Arterial Occlusive Disease |
2.0% |
| Bone Marrow Transplant |
2.0% |
| Constipation |
2.0% |
| Hypoaesthesia |
2.0% |
| Lumbar Spinal Stenosis |
2.0% |
|
| Interstitial Lung Disease |
15.8% |
| Painful Erection |
10.5% |
| Venous Thrombosis |
7.9% |
| Endotoxic Shock |
5.3% |
| Hepatitis Fulminant |
5.3% |
| Pneumonia |
5.3% |
| Rash |
5.3% |
| Rhabdomyolysis |
5.3% |
| Stevens-johnson Syndrome |
5.3% |
| Systemic Lupus Erythematosus |
5.3% |
| Ventricular Tachycardia |
5.3% |
| Aggression |
2.6% |
| Anaphylactoid Reaction |
2.6% |
| Arteriospasm Coronary |
2.6% |
| Ascites |
2.6% |
| Cardio-respiratory Arrest |
2.6% |
| Cerebral Infarction |
2.6% |
| Coma |
2.6% |
| Cytomegalovirus Infection |
2.6% |
| Death |
2.6% |
|
| Concomitant |
| Prophylaxis |
16.7% |
| Drug Use For Unknown Indication |
9.0% |
| Product Used For Unknown Indication |
8.8% |
| Sedation |
6.3% |
| Fluid Replacement |
6.0% |
| Infection |
5.4% |
| Hypertension |
5.3% |
| Prophylaxis Against Graft Versus Host Disease |
5.3% |
| Ureteral Stent Insertion |
4.8% |
| Ureteral Stent Removal |
4.8% |
| Infection Prophylaxis |
3.3% |
| Diuretic Therapy |
3.3% |
| Rheumatoid Arthritis |
3.3% |
| Bone Marrow Conditioning Regimen |
3.1% |
| Hiv Infection |
2.8% |
| Detoxification |
2.6% |
| Antifungal Prophylaxis |
2.4% |
| Insomnia |
2.3% |
| Pain |
2.2% |
| Premedication |
2.2% |
|
| Respiratory Failure |
11.9% |
| Rhabdomyolysis |
7.7% |
| Renal Impairment |
7.0% |
| Somnolence |
7.0% |
| Vomiting |
5.6% |
| White Blood Cell Count Decreased |
5.6% |
| Thrombotic Thrombocytopenic Purpura |
4.9% |
| Weight Increased |
4.9% |
| Hepatic Encephalopathy |
4.2% |
| Premature Baby |
4.2% |
| Pyrexia |
4.2% |
| Venoocclusive Liver Disease |
4.2% |
| Visual Field Defect |
4.2% |
| Bladder Cancer |
3.5% |
| Condition Aggravated |
3.5% |
| Death |
3.5% |
| Disseminated Intravascular Coagulation |
3.5% |
| Drug Ineffective |
3.5% |
| Renal Failure |
3.5% |
| Thrombotic Microangiopathy |
3.5% |
|
| Interacting |
| Prophylaxis |
40.0% |
| Atrial Fibrillation |
20.0% |
| Dyslipidaemia |
20.0% |
| Peripheral Ischaemia |
20.0% |
|
| Hypovolaemic Shock |
100.0% |
|
